Why the study?
The Vizigo visualizable steerable sheath is effective in atrial fibrillation management, but its application in typical atrial flutter ablation remains unexplored.
Does the Vizigo sheath improve procedural efficiency, lesion quality, and recurrence rates compared to a conventional fixed sheath in patients undergoing their first typical atrial flutter ablation?
Does the Vizigo sheath improve procedural efficiency, lesion quality, and recurrence rates compared to a conventional fixed sheath in patients undergoing their first typical atrial flutter ablation?
The use of a visualizable steerable sheath (Vizigo) during typical atrial flutter ablation significantly improves procedural efficiency and lesion quality compared to a conventional fixed sheath, with comparable safety and long-term recurrence rates.
May shorten procedure and fluoroscopy times in flutter ablation; hypothesis-generating for randomized confirmation of outcomes.
OBJECTIVE: The Vizigo sheath, a novel visualizable steerable sheath, has been utilized effectively in the clinical management of atrial fibrillation. However, its application in the ablation of typical atrial flutter (AFL) remains unexplored. This study aims to evaluate and compare the efficacy and safety of the Vizigo sheath against a conventional fixed sheath during catheter ablation for typical AFL. METHODS: This single-center cohort study involved 60 patients undergoing their first AFL ablation procedure. Patients were divided into two groups: the Vizigo sheath group and the fixed sheath group. The primary endpoints included procedural efficiency, lesion quality, and recurrence rates. RESULTS: The Vizigo sheath demonstrated significant advantages over the fixed sheath, including a shorter procedure time (59.8 ± 13.8 vs. 71.5 ± 11.8 min; p = 0.0008) and reduced fluoroscopy duration (0.96 ± 0.32 vs. 1.31 ± 0.24 min; p < 0.0001). The initial bidirectional block rate was also higher in the Vizigo sheath group (84% vs. 68%). A detailed analysis of the cavotricuspid isthmus (CTI) revealed significant differences in the anterior 2/3 of the CTI, where the Vizigo sheath demonstrated greater catheter contact force, higher ablation index, increased force-time integral, and larger impedance drops (all p < 0.05). In contrast, no significant differences were observed between groups in the posterior 1/3 of the CTI. Both groups achieved a 100% acute procedural success rate, with no major complications reported. During a mean follow-up period of 18.68 months, the AFL recurrence rates were comparable between the two groups (p = 0.75). CONCLUSIONS: The Vizigo sheath enhances procedural efficiency and lesion quality during AFL ablation, particularly in challenging anatomical regions, and offers notable advantages over traditional fixed sheaths. Further studies are needed to assess its long-term clinical benefits.
No takes yet. Share an insight, caveat, or question.
Fuding et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: